Details of the Drug

General Information of Drug (ID: DM9AYNN)

• Drug Name: MCO-010

Indication

Disease Entry	ICD 11	Status	REF
Retinitis pigmentosa	9B70	Phase 2	[1]

• Drug Type: Gene therapy
• Cross-matching ID: TTD ID: DE5VG3

References

• [1] ClinicalTrials.gov (NCT04945772) A Phase 2b Randomized, Double-Masked, Sham-Controlled, Study to Evaluate the Efficacy and Safety of Intravitreal Injection of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]. U.S.National Institutes of Health.